Filing Flows › Neuronetics (STIM) › R&D spending
Neuronetics (STIM) R&D spending by quarter
Neuronetics' R&D spending was $1.2M in Q3 2026 (third quarter 2026), -11% from Q2 2026. Over the last 7 quarters it ranged from $1.2M (Q3 2026) to $1.8M (Q2 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.2M | -11% | -21% |
| Q2 2026 | $1.3M | -2% | -26% |
| Q1 2026 | $1.4M | -18% | -16% |
| Q4 2025 | $1.7M | +11% | — |
| Q3 2025 | $1.5M | -16% | — |
| Q2 2025 | $1.8M | +11% | — |
| Q1 2025 | $1.6M | — | — |
Q3 2026 at a glance
Neuronetics, Q3 2026: revenue $42.0M (+12% year over year), operating margin 1.3%, net loss $1.6M, operating cash flow $1.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Neuronetics' R&D spending?
Neuronetics' R&D spending was $1.2M in Q3 2026 (third quarter 2026), -11% from Q2 2026.
How has Neuronetics' R&D spending changed?
Over the last 7 quarters it ranged from $1.2M (Q3 2026) to $1.8M (Q2 2025).